| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/05/1992 | US5110588 Composite salmonella E. coli, Vibrio cholerae vaccine strains |
| 05/05/1992 | US5110587 Immunogenic composition comprising synthetically modified vaccinia virus |
| 05/05/1992 | CA1300013C Attenuated anticoccidial vaccine |
| 05/02/1992 | WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2054830A1 Method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis, and it's formulated medicines |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | WO1992007581A1 Methods and compositions for suppressing allograft rejection in mammals |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 05/01/1992 | CA2054542A1 Chicken anemia virus vaccine and diagnostic |
| 05/01/1992 | CA2054228A1 Muramyldipeptide derivatives and influenza vaccine comprising the derivatives |
| 04/30/1992 | WO1992007084A1 Purified cdw52-specific antibodies |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007077A1 Engineered bacteriophages and vaccines containing them |
| 04/30/1992 | WO1992007002A1 A collagen binding protein as well as its preparation |
| 04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | WO1992006708A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 04/30/1992 | WO1992006704A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 04/30/1992 | WO1992006697A1 Anti-inflammatory composition |
| 04/30/1992 | WO1992006677A1 Artificial viral envelopes |
| 04/30/1992 | WO1991019725A3 Heterocyclic anthracyclione and anthracycline analogs |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2093919A1 Hepatitis c virus antibody |
| 04/30/1992 | CA2054302A1 Monoclonal antibody-containing agent |
| 04/29/1992 | EP0482671A1 Vaccine against varicella-zoster virus |
| 04/29/1992 | EP0482605A2 HTLV-II derived peptide |
| 04/29/1992 | EP0482133A1 Use of lactoferrin to counter the toxic effects of endotoxins. |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482068A1 Cytokine and hormone carriers for conjugate vaccines |
| 04/29/1992 | EP0482061A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5109118 Bonded to lecithin via a chemical linkage; no side effects; anticancer antidiabetic agents |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5109038 Polymer particles which carry, implanted on their surface, amphiphilic molecules carrying ion-forming or reactive groups, a process for the preparation of these particles and their use in biological applications |
| 04/28/1992 | US5109026 2-component immunoadjuvant |
| 04/28/1992 | US5108900 For use in immunoassay to detect pesticides in foods and the environment |
| 04/28/1992 | US5108745 Tuberculosis and legionellosis vaccines and methods for their production |
| 04/28/1992 | US5108744 Vaccines for Haemophilus influenzae |
| 04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/26/1992 | WO1992007582A1 Corynebacteria and related organisms as vaccine vectors |
| 04/26/1992 | CA2094718A1 Corynebacteria and related organisms as vaccine vectors |
| 04/25/1992 | CA2054069A1 Expression system |
| 04/24/1992 | WO1992006710A1 Immunogenic complexes, in particular iscoms |
| 04/23/1992 | WO1992006709A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | CA2094588A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481701A1 Treatment composition |
| 04/22/1992 | EP0481526A1 Chelants |
| 04/22/1992 | EP0481072A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
| 04/22/1992 | CN1060499A Human zona pellucida protein zp3 |
| 04/22/1992 | CN1060498A Recombinant expression vectors capable of expressing immunogenic malarial antigens on surface of salmonella vaccine strains |
| 04/22/1992 | CN1060408A Improved vaccine compositions |
| 04/22/1992 | CN1016315B Process for preparing hepatitis b antigenic compositions |
| 04/21/1992 | USRE33897 Synthetic polypeptides and antibodies related to Epstein-Barr virus nuclear antigen |
| 04/21/1992 | US5106956 Anticarcinogenic agents |
| 04/21/1992 | US5106955 Process for preparation of antibody conjugates |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/21/1992 | US5106951 Antineoplastic anthracyline agents intercalated with two aromatic side chains or an oligopeptide and covalently attached to an antibody |
| 04/21/1992 | US5106877 Including hydroxyalkyl hydrazines; preventing discoloration of teeth from antiplaque agents, food spoilage |
| 04/21/1992 | US5106746 Process for the in vitro immunization of human splenocytes against tumor associated antigens |
| 04/21/1992 | US5106726 Synthetic peptides specific for the detection of antibodies to HCV |
| 04/21/1992 | US5106619 Preparation of inactivated viral vaccines |
| 04/21/1992 | US5106617 Method of treating immature birds with IL-2 |
| 04/21/1992 | US5106616 Administration of acemannan |
| 04/21/1992 | CA1299121C Infectious bovine rhinotracheitis virus mutants, vaccines containingsame, methods for the production of same and methods for the use of same |
| 04/16/1992 | WO1992006193A1 Antibodies directed against cd3 |
| 04/16/1992 | WO1992006120A1 Antigen-antibody conjugates |
| 04/16/1992 | WO1992006105A1 Antibodies and methods for diagnosis and treatment of diabetes |
| 04/16/1992 | WO1992005803A1 Self-assembling ion pair drugs |
| 04/16/1992 | WO1992005800A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 04/16/1992 | WO1992005798A1 Acellular vaccine |
| 04/16/1992 | WO1992005793A1 Targeted immunostimulation with bispecific reagents |
| 04/16/1992 | WO1992004015A3 Regulation of t-cell proliferation via a novel 5ht1a receptor |
| 04/16/1992 | WO1991018618A3 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 04/15/1992 | EP0480525A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 04/15/1992 | EP0480440A1 Monoclonal antibody against melanoma |
| 04/15/1992 | EP0480381A1 Endothelin receptors |
| 04/15/1992 | EP0479971A1 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis |
| 04/15/1992 | EP0479948A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 04/15/1992 | EP0479866A1 Pestivirus nucleotide sequences and polypeptides |
| 04/15/1992 | EP0169234B1 Immunoassay for biologically active human interferon-gamma |
| 04/15/1992 | EP0138826B1 Detection of human chorionic gonadotropin |
| 04/15/1992 | CN1060310A 17 kda protein antigen for immuno diagnosis of tuberculosis and process for producing peptide fragments derived therefrom |
| 04/15/1992 | CN1060294A Improved oligosaccharide conjugate vaccines |
| 04/14/1992 | US5104976 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
| 04/14/1992 | US5104931 Reacting purified antibody with a buffered periodate solution in the presence of a polymer carrier modified with adipic acid dihydrazide |
| 04/14/1992 | US5104652 Compositions and method for treatment of cancer using monoclonal antibody against GD3 ganglioside together with IL-2 |
| 04/13/1992 | WO1992007271A1 Mouse monoclonal antibodies |
| 04/13/1992 | WO1992007270A1 Diagnostic method |
| 04/13/1992 | WO1992007081A2 A monoclonal antibody |
| 04/13/1992 | CA2069417A1 Diagnostic method |
| 04/09/1992 | CA2053017A1 Endothelin receptors |